Navigation Links
Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case
Date:11/5/2007

KENILWORTH, N.J., Nov. 5 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) reported that the U.S. District Court for the District of Massachusetts has found no liability for Warrick Pharmaceuticals, its generic subsidiary, in a class action lawsuit involving several pharmaceutical companies and the setting of average wholesale prices (AWPs) for prescription products.

The Court, in a modification of its prior opinion, ruled that Warrick's AWPs had no effect on Medicare reimbursement and resulted in no damages to class plaintiffs. In June 2007, the Court had issued favorable rulings for the company and dismissed all claims relating to Schering-Plough's branded pharmaceutical products but found limited liability against Warrick with respect to one form of a generic product, albuterol sulfate solution, in the years 1998 and 1999. The Court's latest ruling in favor of the company reverses that finding of limited liability.

"As we move forward with building a company that can deliver sustainable high performance, we are gratified to put another issue from Schering-Plough's past behind us," said Fred Hassan, Schering-Plough chairman and CEO.

The company has consistently maintained that it has complied with all applicable laws and regulations governing pharmaceutical pricing and reimbursement in connection with reporting AWPs.

Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physician
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
2. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
3. Schering-Plough Reports Financial Results for Third Quarter of 2007
4. Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment
5. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
6. Haemacure Reports Third Quarter 2007 Results
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
11. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: O...oreventsinDecember: ,, ASHBriefing ,, ...cipalinvestigatorswilldiscussdatapresentationssurr...lemyeloma,asfeaturedatthe51stAmericanSocietyofHema...LA.Theteleconferencewillbeginat9:00a.m.CT/10:00a.m...
(Date:11/25/2009)...swire/--TheBlackAIDSInstituterecentlyheldBoardofDi...10. ,, ThenewBoardMembersareahighlydiversegroup...,governmenthealthprograms,editorial,andbusinessent...sonalbackgroundsincludingbothheterosexualandgayBla...sentingmultipleagegroups. ,, (Photo: http://www...
(Date:11/25/2009)...f a collaboration between UCLA engineers and physi...0 million Americans who suffer from peripheral art...the arteries, peripheral arterial disease, or PAD,... arteries reduce blood flow to the limbs. The cond...e, heart attack and stroke, and its progression ca...
(Date:11/25/2009)...to overlook needed care, study finds , ,... depression can worsen her child,s asthma, U.S. re...f 262 black mothers and their children found that ...s had more frequent asthma symptoms, while childre...ss frequent asthma symptoms. , The Johns Hopkin...
(Date:11/25/2009)...traightYear ,, WASHINGTON,Nov.25/PRNewswire-U...-GA)issuedthe 4thAnnualReportCardonLungCancer .Thi...slethaldiseaseinthestateofGeorgia.LCA-GAisachapter...iondedicatedexclusivelytopatientsupportandadvocacy...ogo: http://www.newscom.com/cgi-bin/prnh/20081016/...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
... "I worked for General,Shinseki when he was Army ...nd. He is a soldier who has dedicated his life to...en, he knows large organizations, and he knows,Was...ight years, they,deliver outstanding care. Genera...
.... 7 Results of the Phase 2,clinical trial of R788... or,refractory B-Cell non-Hodgkin,s lymphoma (NHL)...ng the 50th Annual American Society of Hematology ...it in,patients suffering from diffuse large B-Cell...
... December 7, 2008) Two studies examining the effe...ll transplantation outcomes will be explored at a ...7, at 8:00 a.m., during the 50th Annual Meeting of...ce of stem cells in cord blood for transplantation...
... Contract negotiations between,the Ohio Nurses Ass...ical,Center (University Hospitals Geneva) broke do..., December 5. To date, the parties have been unabl...va has indicated that they will,remove premium rat...
...st obesity, Americans need to re-learn proper serv...ealthDay News) -- All-you-can-eat buffets, super-s... wallet full, but they,re also helping to expand y...recognizing reasonable portion sizes anymore. , "...
... Klever Innovations has patented a new box...er or damage contents.This revolutionary new tool ...used in the 911 terrorist attacks. Tha Klever Kutt...ol is simple in design, lightweight, and easy to u...
Other Medicine News:Health News:Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL 2Health News:Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL 3Health News:Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL 4Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 2Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 3Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 4Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 5Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 6Health News:University Hospitals Geneva Medical Center Registered Nurses to Strike on December 10 if Contract Agreement Cannot Be Reached 2Health News:Portion Distortion 2Health News:Portion Distortion 3Health News:Revolutionary New Safety Cutter Patented After 911 Terrorist Attacks Is Changing the Way Boxes Are Opened 2
(Date:11/25/2009)... ,, PRINCETON,N.J.,Nov.25/PRNewswire-FirstCa...pharmaceuticalcompanycommittedtodiscovering,develo...ions,reportedfinancialresultsforthefiscalyearended...58.4millionincash,cashequivalentsandshortterminves..., RG7128 ,, Phase2bTrial ,, InlateNo...
(Date:11/25/2009)... ,, WESTPALMBEACH,Fla.,Nov.25/PRNewswire-Fir...icans,especiallythe27millionlivingwithuntreated he...iologistCindyBeyer. ,, Dr.Beyer,seniorvicepresi...ringcareand hearingaids companies,saidstudieshavel...ation,"whichcaneasilybeintensifiedatholidaygatheri...
(Date:11/25/2009)... ,, NEWYORK,Nov.25/PRNewswire/--Reportlinker...leinitscatalogue: ,, UnitedStatesDentalDevices...w.reportlinker.com/p0158733/United-States-Dental-D... ,, UnitedStatesDentalDevicesMarketAnalysisandF...nessentialsourceforin-depthinformationanddatarelat...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12New Editor Named for International Journal Of Nursing Terminologies 26amp 3B Classifications 59323 1New Editor Named for International Journal Of Nursing Terminologies 26amp 3B Classifications 59323 2Capital BlueCross Reaches Out to Former Employees of Turbine Airfoil Designs 59319 1Capital BlueCross Reaches Out to Former Employees of Turbine Airfoil Designs 59319 2Blue Cross Names Three New Executives 59315 1Blue Cross Names Three New Executives 59315 2Blue Cross Names Three New Executives 59315 3
...ne 4 BN,ImmunoTherapeutics, Inc. has initiated Ph...cine candidate against prostate cancer., A Phase ...ents with,non-metastatic as well as hormone-insens...S. Secondary objectives of the trial include exami... antigen-specific immune,responses, as well as cli...
...Molecular Vision -, - Results Show Good Distribut... after a Single Intravitreal Injection -, ...ay announced that a study published in the peer-re...bevasiranib, its siRNA (small,interfering RNA) age...tensive uptake into the retina. In two tissue dist...
Other Medicine Technology:BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine 2Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye 2Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye 3
The Carpal Solution
...mometer that measures temperatures from -50 to 200...splay and minimum/maximum temperature memory. The ...ally, with adhesive, by keyhole or flip-out desk s...accurate to within 1C from -50 to 120C and within ...
...ic pipets without purchasing equipment or interrup...ix vials of Receiver Solution and one or two vial(...or to be verified, the technologist performs six s...ck for analysis and calculation of the results. Wi...
...a sheath fluid when performing analysis by flow cy... dilutes to 3L of sheath fluid with distilled wate...ntrate reduces heavy lifting, increases usable spa...e. Streck Cytometry Concentrate has a closed-vial ...
Medicine Products: